17 Years at AB|18 Years of Experience
Edward Bryan is a Portfolio Manager for the Sustainable Global Small Cap Portfolio, and Senior Research Analyst for the Sustainable Thematic Equities team, responsible for covering the global healthcare sector. He began his career at AB in 2007 as an associate in the Institutional Investments division. In 2010, Bryan became a trading desk analyst in the US Equities Trading department. He joined the research team in 2011. Bryan holds a BA in economics from Franklin & Marshall College and is a CFA charterholder. Location: New York
Despite conventional wisdom, political uncertainty doesn’t necessarily pose acute risks to the healthcare sector.
Vinay Thapar, Edward Bryan | 27 February 2024Technology and creative research should continue to drive company breakthroughs in medicine and packaging.
Edward Bryan, Vinay Thapar | 01 November 2022ESG ratings are lacking for small-cap stocks globally. This prevents asset managers that rely on third-party ratings from building small-cap funds.
Edward Bryan, Dan Roarty | 25 August 2022Can solutions to supply chain disruptions be found in a fermentation tank? The crisis could accelerate the adoption of synthetic biology to ensure sustainable supply of many products.
Edward Bryan | 08 April 2022Synthetic biology is not science fiction. Investors should get acquainted with a technology that will create sustainable solutions in many industries.
Sarah Tunnell, Edward Bryan | 13 January 2022As the transformational science of synthetic biology makes a growing impact on more industries, equity investors will find exciting opportunities.
Edward Bryan | 23 November 2021Diagnostics - the back-end robotics in the health care system - are helping automate many complex procedures. Diagnostics are not only increasingly aiding the treatment of patients with infectious diseases but accelerating the broader trend toward personalized health care.
Dan Roarty, Edward Bryan | 24 August 2020This is a marketing communication. This information is provided by AllianceBernstein Schweiz AG, Zürich, a company registered in Switzerland under company number CHE-306.220.501. AllianceBernstein Schweiz AG is a financial service provider within the meaning of the Financial Services Act (FinSA) which is not subject to any prudential supervision in Switzerland. Further information on the company, its services and products, in accordance with Art. 8 FinSA can be found on the Important Disclosures page at www.alliancebernstein.com. It is provided for informational purposes only and does not constitute investment advice or an invitation to purchase any security or other investment nor is it a recommendation to subscribe to a financial service. The views and opinions expressed are based on our internal forecasts and should not be relied upon as an indication of future market performance. The value of an investment can go down as well as up and investors may not get back the full amount they invested. Capital is at risk. Past performance does not guarantee future results.
This information is directed at Qualified Investors only and is not intended for public use.